Primary vitreoretinal lymphoma
FDA rejects Aldeyra’s eye cancer treatment, citing a lack of clinical data, shattering hopes
SG Tylor
Source – Aldeyra Therapeutics On June 21, 2023, Aldeyra disclosed that they have received a Complete Response Letter from the ...
